Assessing sample representativeness in randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network

被引:49
|
作者
Susukida, Ryoko [1 ]
Crum, Rosa M. [1 ,2 ,3 ]
Stuart, Elizabeth A. [1 ]
Ebnesajjad, Cyrus [1 ]
Mojtabai, Ramin [1 ,3 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mental Hlth, 624 North Broadway Room 897, Baltimore, MD 21205 USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA
关键词
Clinical trials; sample representativeness; substance use disorders; MOTIVATIONAL ENHANCEMENT THERAPY; BUPRENORPHINE-NALOXONE; SOCIOECONOMIC-STATUS; SUBSTANCE-ABUSE; GENERALIZABILITY; DEPENDENCE; INCENTIVES; PREDICTORS; EDUCATION; SELECTION;
D O I
10.1111/add.13327
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Aims To compare the characteristics of individuals participating in randomized controlled trials (RCTs) of treatments of substance use disorder (SUD) with individuals receiving treatment in usual care settings, and to provide a summary quantitative measure of differences between characteristics of these two groups of individuals using propensity score methods. Design Analyses using data from RCT samples from the National Institute of Drug Abuse Clinical Trials Network (CTN) and target populations of patients drawn from the Treatment Episodes Data Set-Admissions (TEDS-A). Settings Multiple clinical trial sites and nation-wide usual SUD treatment settings in the United States. Participants A total of 3592 individuals from 10 CTN samples and 1 602 226 individuals selected from TEDS-A between 2001 and 2009. Measurements The propensity scores for enrolling in the RCTs were computed based on the following nine observable characteristics: sex, race/ethnicity, age, education, employment status, marital status, admission to treatment through criminal justice, intravenous drug use and the number of prior treatments. Findings The proportion of those with >= 12 years of education and the proportion of those who had full-time jobs were significantly higher among RCT samples than among target populations (in seven and nine trials, respectively, at P < 0.001). The pooled difference in the mean propensity scores between the RCTs and the target population was 1.54 standard deviations and was statistically significant at P < 0.001. Conclusions In the United States, individuals recruited into randomized controlled trials of substance use disorder treatments appear to be very different from individuals receiving treatment in usual care settings. Notably, RCT participants tend to have more years of education and a greater likelihood of full-time work compared with people receiving care in usual care settings.
引用
收藏
页码:1226 / 1234
页数:9
相关论文
共 50 条
  • [1] Generalizability of findings from randomized controlled trials: application to the National Institute of Drug Abuse Clinical Trials Network
    Susukida, Ryoko
    Crum, Rosa M.
    Ebnesajjad, Cyrus
    Stuart, Elizabeth A.
    Mojtabai, Ramin
    ADDICTION, 2017, 112 (07) : 1210 - 1219
  • [2] A centralized informatics infrastructure for the National Institute on Drug Abuse Clinical Trials Network
    Pon, Jeng-Jong
    Nahm, Meredith
    Wakim, Paul
    Cushing, Carol
    Poole, Lori
    Tai, Betty
    Pieper, Carl F.
    CLINICAL TRIALS, 2009, 6 (01) : 67 - 75
  • [3] Increasing Ethnic Minority Participation in Substance Abuse Clinical Trials: Lessons Learned in the National Institute on Drug Abuse's Clinical Trials Network
    Burlew, Kathleen
    Larios, Sandra
    Suarez-Morales, Lourdes
    Holmes, Beverly
    Venner, Kamilla
    Chavez, Roberta
    CULTURAL DIVERSITY & ETHNIC MINORITY PSYCHOLOGY, 2011, 17 (04): : 345 - 356
  • [4] Gender Research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: A Summary of Findings
    Greenfield, Shelly F.
    Rosa, Carmen
    Putnins, Susan I.
    Green, Carla A.
    Brooks, Audrey J.
    Calsyn, Donald A.
    Cohen, Lisa R.
    Erickson, Sarah
    Gordon, Susan M.
    Haynes, Louise
    Killeen, Therese
    Miele, Gloria
    Tross, Susan
    Winhusen, Theresa
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2011, 37 (05): : 301 - 312
  • [5] Treatment programs in the National Drug Abuse Treatment Clinical Trials Network
    McCarty, Dennis
    Fuller, Bret
    Kaskutas, Lee Ann
    Wendt, William W.
    Nunes, Edward V.
    Miller, Michael
    Forman, Robert
    Magruder, Kathryn M.
    Arfken, Cynthia
    Copersino, Marc
    Floyd, Anthony
    Sindelark, Jody
    Edmundson, Eldon
    DRUG AND ALCOHOL DEPENDENCE, 2008, 92 (1-3) : 200 - 207
  • [6] Buprenorphine adoption in the National Drug Abuse Treatment Clinical Trials Network
    Knudsen, Hannah K.
    Abraham, Amanda J.
    Johnson, J. Aaron
    Roman, Paul M.
    JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2009, 37 (03) : 307 - 312
  • [7] The training documentation form - Going beyond the basics for the national institute on drug abuse (NIDA) national drug abuse treatment clinical trials network (CTN)
    Williams, Tracee
    Kondapaka, Radhika
    Shmueli-Blumberg, Dikla
    Wright, Matthew
    Salazar, Dagmar
    Williams, Kayla
    Collins, Julia
    Jelstrom, Eve
    Lindblad, Robert
    TRIALS, 2017, 18
  • [8] Quality assurance of research protocols conducted in the community: The National Institute on Drug Abuse Clinical Trials Network Experience
    Rosa, Carmen
    Campbell, Aimee
    Kleppinger, Cynthia
    Sampson, Royce
    Tyson, Clare
    Mamay-Gentilin, Stephanie
    CLINICAL TRIALS, 2009, 6 (02) : 151 - 161
  • [9] Retention in the National Institute on Drug Abuse Clinical Trials Network Women and Trauma Study: Implications for Posttrial Implementation
    Pinto, Rogerio M.
    Campbell, Aimee N. C.
    Hien, Denise A.
    Yu, Gary
    Gorroochurn, Prakash
    AMERICAN JOURNAL OF ORTHOPSYCHIATRY, 2011, 81 (02) : 211 - 217
  • [10] Peer Intervention to Link Overdose Survivors to Treatment (PILOT):Protocol for a Multisite, Randomized Controlled Trial Conducted Within the National Institute on Drug Abuse Clinical Trials Network
    Papa, Carrie
    McClure, Erin A.
    McCauley, Jenna
    Haynes, Louise
    Matheson, Timothy
    Jones, Richard
    Jennings, Lindsey
    Lawdahl, Tricia
    Ward, Ralph
    Brady, Kathleen
    Barth, Kelly Stephenson
    JMIR RESEARCH PROTOCOLS, 2024, 13